Approved the manufacture and sale of the drug “donanemab” for Alzheimer's disease ✌️
Everyone, is the antenna 📡 properly detachable ☝️
On the 1st, the expert committee of the Ministry of Health, Labor, and Welfare approved manufacturing and sales approval for the Alzheimer's disease treatment drug “donanemab” (trade name kesanra) by US pharmaceutical giant Eli Lilly. It is second only to lecanemab developed by Japanese pharmaceutical giant Eisai and others in the type of drug that removes substances that cause illness. It is expected that public insurance will also be applied in November.
Donanemab removes clumps of the abnormal protein “amyloid beta (Abeta)” that accumulates in the patient's brain and suppresses the progression of the disease. The target is patients with early-stage Alzheimer's disease, including people with mild cognitive impairment (MCI), which is the antecedent stage of dementia. It is administered once a month by infusion, and if loss of Abeta lumps can be confirmed by testing around 1 year, administration is discontinued. You can receive administration for up to one and a half years.
It was approved in the US on July 2, and in Japan, an approval application was submitted to the Ministry of Health, Labor, and Welfare in August last year. The annual treatment cost in the United States is approximately 32,000 dollars (about 4.8 million yen). Drug prices (public prices) in Japan are expected to be discussed by the Minister of Health, Labor, and Welfare's advisory body and the Central Social Insurance and Medical Council.
Recanemab was approved domestically in September last year, and has been used in medical insurance since December.
Recanemab was approved domestically in September last year, and has been used in medical insurance since December.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
個別（NVDU、TSLL）&投資信託（FANG、レバFANG、トップ10、ノムハン、レバナス、レバドラ）＆ETF（178A、2243、2244）運用中✌️
346Followers
122Following
1401Visitors
Follow